OSR Holdings, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OSR Holdings, Inc. (OSRH) on April 16, 2026. The report discloses the appointment of a new Chief Operating Officer effective April 16, 2026. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Bellevue, WA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive personnel changes and compensation arrangements.
Material Changes
The primary material change reported is the appointment of Yeiseok Kim as Chief Operating Officer, effective April 16, 2026. Mr. Kim previously served as a Senior Analyst at OSR Holdings Co., Ltd. (a subsidiary) from 2020 to 2025, supporting cross-border healthcare investments and pharmaceutical licensing.
Management Commentary and Compensation
In connection with his appointment, Mr. Kim entered into an amended employment agreement with OSR Holdings Co., Ltd. reflecting an increase in annual compensation. The terms include:
- Base salary of KRW 240,000,000 per year.
- Participation in the Company's Equity-based Compensation Plan, subject to the Compensation Committee's discretion.
- Other customary benefits available to executive officers.
The Board approved the appointment on March 26, 2026. The filing states there are no family relationships between Mr. Kim and any director or executive officer, and no undisclosed arrangements regarding his appointment.
Investor Verification Checklist
- Verify the exact effective date of the COO appointment (April 16, 2026).
- Confirm the base salary amount in KRW (240,000,000) and any potential currency conversion impacts.
- Review future filings for details on the specific equity awards granted under the Compensation Committee's discretion.
- Assess Mr. Kim's prior experience in cross-border healthcare investments relative to the Company's strategic direction.